Nalda

Adenoviral Vectors for Gene Therapy

Curiel David T. | 9780323898218 | Englisch | 2025 | Elsevier
9780323898218
Innert 15 Tagen geliefert
40 Tage Rückgabe
Hardcover
CHF 191.05

Produktinformationen

Beschreibung

Adenoviral Vectors for Gene Therapy, Third Edition, provides detailed, comprehensive coverage of gene delivery vehicles based on the adenovirus that is emerging as an important tool in gene therapy. These exciting new therapeutic agents have great potential for the treatment of disease, as platforms for gene therapy and gene editing, as well as for oncology approaches, making them class leading agents in the gene-advanced therapies arena.

The fully updated and expanded third edition covers the basic biology of adenoviruses and highlights the potential use of adenoviral vectors for the treatment of disease, including their construction, propagation, and purification, cutting-edge vectorology, and the use of adenoviral vectors in preclinical animal models. The book also considers the regulatory issues surrounding human clinical gene therapy trials. New chapters include adenoviral vaccines for veterinary applications, adenoviruses for gene editing, nonhuman primate adenoviruses, COVID-19 vaccines, vaccine applications, and oncolytic adenoviruses for antitumor immunization. This broad scope of information provides a solid overview of the field, allowing the reader to gain a complete understanding of the development and use of adenoviral vectors.
Spezifikationen
Jahr 2025
Autor Curiel David T.
Format Hardcover
Sprache Englisch
Gewicht (g) 2020
Breite (mm) 191
Länge (mm) 235
Verlag Elsevier
Versand-Gewicht (g) 2020
Versand-Breite (mm) 235
Versand-Höhe (mm) 191
Versand-Länge (mm) 223
Sold by Nalda AG